Interleukin-1beta promoter (-31T/C and -511C/T) polymorphisms in major recurrent depression

Journal of Molecular Neuroscience

Volumn 44, Issue 1, 2011, Pages 12-16

  Borkowska, Paulina ^a   Kucia, Krzysztof ^a   Rzezniczek, Szymon ^a   Paul Samojedny, Monika ^a   Kowalczyk, Malgorzata ^a   Owczarek, Aleksander ^a   Suchanek, Renata ^a   Medrala, Tomasz ^a   Kowalski, Jan ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Genetic association studies; Interleukin 1beta; Major recurrent depression; Polymorphism

Indexed keywords

INTERLEUKIN 1BETA;

ADULT; AGED; ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CORRESPONDENCE ANALYSIS; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HAMILTON SCALE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; ONSET AGE; POLYMERASE CHAIN REACTION; PROMOTER REGION; RECURRENT DISEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; DEPRESSIVE DISORDER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; QUESTIONNAIRES; RECURRENCE; YOUNG ADULT;

EID: 79955907266     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-011-9507-5     Document Type: Article

References (32)

1. Andrews G, Poulton R, Skoog I (2005) Lifetime risk of depression: restricted to a minority or waiting for most? Br J Psychiatry 187:495-496
2. Anisman H, Ravindran AV, Griffiths J, Merali Z (1999) Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiatry 4:182-188 (Pubitemid 29163982)
3. Capuron L, Ravaud A, Dantzer R (2000) Early depressive symptoms in cancer patients receiving interleukin 2 and/or interferon alfa-2b therapy. J Clin Oncol 18:2143-2151 (Pubitemid 30324368)
4. Chen H, Wilkins LM, Nazneen A, Cannings Ch, Wyllie DH, Bingle C et al (2006) Single nucleotide polymorphisms in the human interleukin-1B gene affect transcription according to haplotype context. Hum Mol Genet 4:519-529 (Pubitemid 43205418)
5. Connor TJ, Leonard BE (1998) Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci 62:583-606 (Pubitemid 28045567)
6. Dantzer R (2004) Cytokine-induced sickness behavior: a neuroimmune response to activation of innate immunity. Eur J Pharmacol 500:399-411
7. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA et al (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398-402 (Pubitemid 30164342)
8. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA et al (2001) The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 412:99
9. First MB, Spitzer RL, Gibbon M, Williams JBW (1997) Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). American Psychiatric, Washington
10. Ghaemi SN, Ko JY, Goodwin FK (2001) The bipolar spectrum and the antidepressant view of the world. J Psychiatr Pract 7:287-297
11. Grimaldi L, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G et al (2000) Association of early-onset Alzheimer's disease with an interleukin-1α gene polymorphism. Ann Neurol 47:361-368
12. Hall SK, Perregaux DG, Gabel CA, Woodworth T, Durham LK, Huizinga TW et al (2004) Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 50:1976-1983 (Pubitemid 38725110)
13. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278-296
14. Hirschfeld RMA, Williams JBW, Spitzer RL, Calabrese JR, Flynn L, Keck PE et al (2000) Development and validation of a screening instrument for bipolar spectrum disorder: the mood disorder questionnaire. Am J Psychiatry 157:1873-1874
15. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY et al (2002) Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 123:1793-1803 (Pubitemid 35408303)
16. Kagaya A, Kugaya A, Takebayashi M, Fukue-Saeki M, Seaki T, Yamawaki S (2001) Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor Ralpha of depressed patients in Japan. Neuropsychobiology 43:59-62 (Pubitemid 32149726)
17. Katila H, Hanninen K, Hurme M (1999) Polymorphisms of the interleukin-1 gene complex in schizophrenia. Mol Psychiatry 4:179-181 (Pubitemid 29163981)
18. Kimura R, Nishioka T, Soemantri A, Ishida T (2004) Cis-acting effects of the IL1B C-31T polymorphism on IL-1β mRNA expression. Genes Immun 5:572-575 (Pubitemid 39529974)
19. Khairova RA, Machado-Vieira R, Du J, Manji HK (2009) A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder. Int J Neuropsychopharmacol 12:561-578
20. Kubera M, Kenis G, Bosmans E, Zieba A, Dudek D, Nowak G, Maes M (2000) Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol J Pharmacol 52:237-241 (Pubitemid 30479574)
21. Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V (1999) Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 40:171-176 (Pubitemid 29515729)
22. McCulley MC, Day IN, Holmes C (2004) Association between interleukin 1-β promoter (-511) polymorphism and depressive symptoms in Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 124:50-53 (Pubitemid 38031592)
23. Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65:732-741
24. Misener VL, Gomez L, Wigg KG, Luca P, King N, Kiss E et al (2008) Cytokine genes TNF, IL1A, IL1B, IL6, IL1RN and IL10, and childhood-onset mood disorders. Neuropsychobiology 58:71-80
25. Owen BM, Eccleston D, Ferrier IN, Young AH (2001) Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand 103:226-228 (Pubitemid 32154355)
26. Papiol S, Rosa A, Gutierrez B, Martin B, Salgado P, Catalan R et al (2004) Interleukin-1 cluster is associated with genetic risk for schizophrenia and bipolar disorder. J Med Genet 41:219-223 (Pubitemid 38333802)
27. Pociot F, Molving J, Wogensen L, Worsaae H, Nerup J (1992) A TaqI polymorphism in the human interleukin-1beta (IL-1beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Investig 22:396-402
28. Rosa A, Peralta V, Papiol S, Cuesta MJ, Serrano F, Martinez-Larrea A, Fananas L (2004) Interleukin-1β (IL-1β) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders. Am J Med Genet B Neuropsychiatr Genet 124:10-14 (Pubitemid 38031585)
29. Santtila S, Savinainen K, Hurme M (1998) Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 47:195-198 (Pubitemid 28153395)
30. Sluzewska A (1999) Indicators of immune activation in depressed patients. Adv Exp Med Biol 461:59-73
31. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ (2004) Global burden of depressive disorders in the year 2000. Br J Psychiatry 184:386-392 (Pubitemid 38624764)
32. Yu YW, Chen TJ, Hong CJ, Chen HM, Tsai SJ (2003) Association study of the interleukin-1β(C-511T) genetic polymorphisms with major depressive disorder, associated symtomatology, and anti-depressant response. Neuropsychopharmacology 28:1182-1185